CREB1 and obesity disorder: Several clinical trials demonstrated that a potent CREB activator forskolin could be beneficial for asthma, obesity, and inflammatory diseases treatment.[22, 23, 24] To explore whether forskolin could aid IVDD progression by activating CREB signaling, we microinjected forskolin to NP site to induce enhancement of CREB signaling (Figure8A).